Predictors of malignancy in patients with pheochromocytomas/paragangliomas: Asian Indian experience
dc.contributor.author | Khadilkar, K. | |
dc.contributor.author | Sarathi, V. | |
dc.contributor.author | Kasaliwal, R. | |
dc.contributor.author | Malhotra, G. | |
dc.date.accessioned | 2017-06-19T09:40:29Z | |
dc.date.available | 2017-06-19T09:40:29Z | |
dc.date.issued | 2016 | |
dc.description.division | RMC | en |
dc.format.extent | 5081 bytes | |
dc.format.mimetype | text/html | |
dc.identifier.source | Endocrine Connections, 2016. Vol. 5: pp. 89-97 | en |
dc.identifier.uri | http://hdl.handle.net/123456789/14618 | |
dc.language.iso | en | en |
dc.subject | malignant pheochromocytoma | en |
dc.subject | malignant paraganglioma | en |
dc.subject | clinical predictors | en |
dc.subject | 18F-flurodeoxyglucose PET/CT | en |
dc.title | Predictors of malignancy in patients with pheochromocytomas/paragangliomas: Asian Indian experience | en |
dc.type | Article | en |